Cannabinoids overall are likely to be helpful for headache sufferers due to their ability to penetrate the part of the brain involved in migraine pathophysiology.

Did you know that 23 million Americans suffer from severe migraine headaches, and 25% have four or more episodes per month?

In fact, this epidemic costs businesses between 1.2 billion to 17.2 billion dollars annually, through lost productivity and sick time.

A team of researchers with the University of Toronto’s School of Public Health opined, “Cannabis vaporizer use can reduce the emission of carbon monoxide, chronic respiratory symptoms, and exposure to several toxins while producing similar subjective effects and blood THC concentration compared with smoking cannabis, holding potential for harm reduction among habitual cannabis smokers.”

During the past few years, there has been growing popularity regarding CBD, or cannabidiol. It is one of the two main substances that is isolated from hemp.

Many people enjoy using CBD to treat a wide variety of health issues, including depression, anxiety, and stress relief. Because depression is an issue that impacts people worldwide, new treatment options have been developed, including CBD.

If you are struggling with depression, reach out to a mental health professional who can help you develop a comprehensive treatment plan that includes therapy, which might include CBD.

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in cannabis, is pleased to announce that the Company’s research partner McMaster University (the “Researcher”) has received a no objection letter from Health Canada to proceed with research with MediPharm Labs CBD50 and CBD10:2. This is a key milestone in moving forward with the Company’s strategy to be the go-to cannabis partner for pharmaceuticals containing cannabis.

True Leaf Brands Inc. (MJ) (CSE.MJ, OTC: TRLFF, Forum) has announced it has submitted an application to Health Canada for an amendment to its Standard Processing License for the Sale of Dried Cannabis.

The amended license will permit True Leaf to sell its craft cannabis products directly to medical patients and retail distributors nationwide.

Darcy Bomford, CEO of True Leaf, commented:

As per the report produced by the International Federation of Psoriasis Association, approx.125 million people have psoriasis across the globe. The widespread prevalence of this skin condition makes it a global health concern, which is why experts have been working rigorously to find a solution for this disease. 

There is no proven cure for psoriasis, but there are some ways to treat or manage the symptoms of this disease. One solution that has been discovered recently and has become increasingly popular is CBD oils on the skin affected by psoriasis to heal and consume the CBD oil orally to help with the immune system. If you search google for “Best CBD Oil Canada,” you will come across at least one article talking about using CBD oil for treating psoriasis. 

As recreational cannabis use increases, so has the number of calls regarding dogs who have accidentally consumed cannabis products

Photo by James Barker on Unsplash

In the past few years, opioids and cannabinoids have received a great deal of attention from the media and public health authorities.

Finding yourself a little more stressed than usual lately? Maybe find some time to light a few candles and soak in the tub with an amazing bath soak made from all-natural ingredients like hemp seed oil, Epsom salt, magnesium, lavender, and more.

A calming lavender oil mixed with eucalyptus and camphor engages your senses and helps quiet your mind. Other minerals and oils work together to keep your skin incredibly soft and completely hydrated. The Prima Bath Gem is 100% free of parabens and synthetic fragrance.

New York, US, Aug. 24, 2021 (GLOBE NEWSWIRE) -- CBD Skincare Products Market Overview

According to a comprehensive research report by Market Research Future (MRFR), “CBD Skincare Products Market Information by Product Type, Category, Distribution Channel and Region - Forecast till 2028”, the market is projected to Grow at a 29.1% CAGR from 2021 to 2028.

Major Growth Boosters